TELA Bio Sees FY23 $57M-$60M Vs $61.64M Est.
Portfolio Pulse from Benzinga Newsdesk
TELA Bio has projected its FY23 revenue to be between $57M and $60M, which is lower than the estimated $61.64M.
November 09, 2023 | 11:05 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
TELA Bio's lower than expected FY23 revenue forecast may negatively impact its stock price in the short term.
TELA Bio's FY23 revenue forecast is lower than the market's estimate. This could lead to a negative sentiment among investors, potentially causing a short-term decrease in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100